On the back of an aggressive branding showcase managed by India Brand Equity Foundation (IBEF), the Brand India Pharma campaign made its presence felt on the first day of CPhI Worldwide 2014. With a 360-degree strategy, IBEF has been leading the Brand India Pharma campaign since its launch in March 2012 under the aegis of the Department of Commerce.
This is the third consecutive presence of the campaign at CPhI Worldwide, one of the most prestigious pharmaceutical events across the globe. Around 230 Indian companies are participating at CPhI Worldwide this year. CPhI Worldwide is the largest pharmaceutical trade exhibition held from October 7 to 9, 2014 in Paris.
The India pavilion was inaugurated by Rajeev Kher, commerce secretary, Government of India along with Arun Kumar Singh, ambassador of India to France, Dr G N Singh, drugs controller general of India, B P Pandey, additional secretary and financial advisor, department of commerce; Sudhanshu Pandey, joint secretary, department of commerce; Aparna Dutt Sharma, chief executive officer, IBEF, Amruth Rao, licensing authority, DCA, Telangana, H G Koshia, commissioner, Food & Drug Control Administration, Gujarat and Dr P V Appaji, director general, Pharmaceuticals Export Promotion Council of India (Pharmexcil) in the presence of major Indian pharmaceutical companies in Hall 6 at the Paris Nord Villepinte, France.
“The Indian pharmaceutical industry stands with the full support of the Government of India. For instance, our increasing participation at global exhibitions like CPhI Worldwide demonstrates the commitment to the sector. There are around five Indian companies in the list of top 20 global generic companies. Indian companies are looking at making healthcare accessible and affordable for the global population,”said Sudhanshu Pandey.
The Brand India Pharma also made an impacting presence at the pre-connect congress that took place on October 6, 2014. Speakers like Sudhanshu Pandey, Dr Appaji from Pharmexcil, Nithya Balasubramanian, head, global portfolio management, Cipla and C Bharat Reddy, executive director, MSN Laboratories shared perspectives from India on various topics ranging from comparative view of the Chinese, Indian and Brazilian API sourcing markets, strategic alliances and partnering, changing outsourcing strategies, strategic alliances of pharmaceutical companies and the future of healthcare business models.
IBEF has coordinated meetings of the high-level Indian delegation with the global pharmaceutical media and Indian companies during the three days of the event. An interactive session of the Indian delegation with the local French media and industry was jointly organised by IBEF and The Embassy of India in Paris on October 6, 2014.
India’s positioning of a responsible healthcare provider has found resonance amongst the meetings held during the pre-connect congress and the first day of the exhibition. Major Indian companies have adopted the Rx India Responsible Healthcare in their pavilions making it a consolidated effort from India to spread awareness about the strengths of the Indian pharmaceutical industry.
The focused activities undertaken by IBEF as part of the Brand India Pharma campaign this year at CPhI Worldwide are expected to increase awareness about the Indian pharmaceutical industry amongst the global stakeholders.